Molecular findings among patients referred for clinical whole-exome sequencing
- PMID: 25326635
- PMCID: PMC4326249
- DOI: 10.1001/jama.2014.14601
Molecular findings among patients referred for clinical whole-exome sequencing
Abstract
Importance: Clinical whole-exome sequencing is increasingly used for diagnostic evaluation of patients with suspected genetic disorders.
Objective: To perform clinical whole-exome sequencing and report (1) the rate of molecular diagnosis among phenotypic groups, (2) the spectrum of genetic alterations contributing to disease, and (3) the prevalence of medically actionable incidental findings such as FBN1 mutations causing Marfan syndrome.
Design, setting, and patients: Observational study of 2000 consecutive patients with clinical whole-exome sequencing analyzed between June 2012 and August 2014. Whole-exome sequencing tests were performed at a clinical genetics laboratory in the United States. Results were reported by clinical molecular geneticists certified by the American Board of Medical Genetics and Genomics. Tests were ordered by the patient's physician. The patients were primarily pediatric (1756 [88%]; mean age, 6 years; 888 females [44%], 1101 males [55%], and 11 fetuses [1% gender unknown]), demonstrating diverse clinical manifestations most often including nervous system dysfunction such as developmental delay.
Main outcomes and measures: Whole-exome sequencing diagnosis rate overall and by phenotypic category, mode of inheritance, spectrum of genetic events, and reporting of incidental findings.
Results: A molecular diagnosis was reported for 504 patients (25.2%) with 58% of the diagnostic mutations not previously reported. Molecular diagnosis rates for each phenotypic category were 143/526 (27.2%; 95% CI, 23.5%-31.2%) for the neurological group, 282/1147 (24.6%; 95% CI, 22.1%-27.2%) for the neurological plus other organ systems group, 30/83 (36.1%; 95% CI, 26.1%-47.5%) for the specific neurological group, and 49/244 (20.1%; 95% CI, 15.6%-25.8%) for the nonneurological group. The Mendelian disease patterns of the 527 molecular diagnoses included 280 (53.1%) autosomal dominant, 181 (34.3%) autosomal recessive (including 5 with uniparental disomy), 65 (12.3%) X-linked, and 1 (0.2%) mitochondrial. Of 504 patients with a molecular diagnosis, 23 (4.6%) had blended phenotypes resulting from 2 single gene defects. About 30% of the positive cases harbored mutations in disease genes reported since 2011. There were 95 medically actionable incidental findings in genes unrelated to the phenotype but with immediate implications for management in 92 patients (4.6%), including 59 patients (3%) with mutations in genes recommended for reporting by the American College of Medical Genetics and Genomics.
Conclusions and relevance: Whole-exome sequencing provided a potential molecular diagnosis for 25% of a large cohort of patients referred for evaluation of suspected genetic conditions, including detection of rare genetic events and new mutations contributing to disease. The yield of whole-exome sequencing may offer advantages over traditional molecular diagnostic approaches in certain patients.
Conflict of interest statement
Comment in
-
Genome-scale sequencing in clinical care: establishing molecular diagnoses and measuring value.JAMA. 2014 Nov 12;312(18):1865-7. doi: 10.1001/jama.2014.14665. JAMA. 2014. PMID: 25326641 No abstract available.
Similar articles
-
Clinical exome sequencing for genetic identification of rare Mendelian disorders.JAMA. 2014 Nov 12;312(18):1880-7. doi: 10.1001/jama.2014.14604. JAMA. 2014. PMID: 25326637 Free PMC article.
-
Clinical whole-exome sequencing for the diagnosis of mendelian disorders.N Engl J Med. 2013 Oct 17;369(16):1502-11. doi: 10.1056/NEJMoa1306555. Epub 2013 Oct 2. N Engl J Med. 2013. PMID: 24088041 Free PMC article.
-
Diagnostic Impact and Cost-effectiveness of Whole-Exome Sequencing for Ambulant Children With Suspected Monogenic Conditions.JAMA Pediatr. 2017 Sep 1;171(9):855-862. doi: 10.1001/jamapediatrics.2017.1755. JAMA Pediatr. 2017. PMID: 28759686 Free PMC article.
-
[Genetic testing in the fetus and child].Ther Umsch. 2013 Nov;70(11):621-31. doi: 10.1024/0040-5930/a000457. Ther Umsch. 2013. PMID: 24168795 Review. German.
-
Recommendations for returning genomic incidental findings? We need to talk!Genet Med. 2013 Nov;15(11):854-9. doi: 10.1038/gim.2013.113. Epub 2013 Aug 1. Genet Med. 2013. PMID: 23907645 Free PMC article. Review.
Cited by
-
Exome sequencing in four families with neurodevelopmental disorders: genotype-phenotype correlation and identification of novel disease-causing variants in VPS13B and RELN.Mol Genet Genomics. 2024 May 21;299(1):55. doi: 10.1007/s00438-024-02149-y. Mol Genet Genomics. 2024. PMID: 38771357
-
CNVoyant: A Highly Performant and Explainable Multi-Classifier Machine Learning Approach for Determining the Clinical Significance of Copy Number Variants.Res Sq [Preprint]. 2024 Apr 30:rs.3.rs-4308324. doi: 10.21203/rs.3.rs-4308324/v1. Res Sq. 2024. PMID: 38746157 Free PMC article. Preprint.
-
Expanding phenotype of MED13-associated syndrome presenting novel de novo missense variant in a patient with multiple congenital anomalies.BMC Med Genomics. 2024 May 14;17(1):130. doi: 10.1186/s12920-024-01857-z. BMC Med Genomics. 2024. PMID: 38745205 Free PMC article.
-
Evaluation of 100 Dutch cases with 16p11.2 deletion and duplication syndromes; from clinical manifestations towards personalized treatment options.Eur J Hum Genet. 2024 Apr 11. doi: 10.1038/s41431-024-01601-2. Online ahead of print. Eur J Hum Genet. 2024. PMID: 38605127
-
An adult with cystathionine beta-synthase deficiency, camptodactyly-arthropathy-coxa vara-pericarditis syndrome, and deafness: A case report.Genet Mol Biol. 2024 Apr 8;47(1):e20220335. doi: 10.1590/1678-4685-GMB-2022-0335. eCollection 2024. Genet Mol Biol. 2024. PMID: 38593426 Free PMC article.
References
-
- Shevell M, Ashwal S, Donley D, et al. Quality Standards Subcommittee of the American Academy of Neurology; Practice Committee of the Child Neurology Society. Practice parameter: evaluation of the child with global developmental delay: report of the Quality Standards Subcommittee of the American Academy of Neurology and The Practice Committee of the Child Neurology Society. Neurology. 2003;60(3):367–380. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases